Company intelligence / Profile preview

Ameritox

Baltimore, Maryland, United States

Ownership: Private
Employees: ~311
Development stage: Other

Overview

Ameritox ceased operations in 2018 after selling its book of business and auctioning off assets. The company was a leader in urine drug monitoring for chronic pain patients, providing physicians with proprietary testing and reporting tools to assess medication adherence and identify potential misuse or abuse.

Industry: Metabolite Diagnostics

Partnerships

Genex Services (acquired PRIUM subsidiary in 2017)Thomas Jefferson University Jefferson School of Population Health (research collaboration)

Beyond the preview

Go deeper on Ameritox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ameritox.

Explore the full profile